{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:06:06Z","timestamp":1781579166233,"version":"3.54.5"},"reference-count":24,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations leading to red cell enzyme deficiencies can be associated with diverse phenotypes that range from hemolytic anemia, methemoglobinemia, polycythemia, and neurological and developmental abnormalities. While most of these mutations occur sporadically, some such as common glucose-6-phosphate dehydrogenase (G6PD) mutants are endemic and rarely cause disease. Common G6PD mutants likely reached their prevalence because they provide some protection against severe malarial complications. In this review G6PD, pyruvate kinase, 5\u2032 nucleotidase, and cytochrome b5 reductase deficiencies will be discussed in greater detail. Limitations of commonly used screening tests for detection of these disorders will also be emphasized, as well as emerging knowledge about non-enzymatic function of the glycolytic enzymes.<\/jats:p>","DOI":"10.1182\/asheducation-2005.1.19","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T01:29:34Z","timestamp":1132709374000},"page":"19-23","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":50,"title":["Red Cell Enzymes"],"prefix":"10.1182","volume":"2005","author":[{"given":"Josef T.","family":"Prchal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xylina T.","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111702150470300_R1","unstructured":"Beutler E. Glucose-6-phosphate dehydrogenase deficiency and other red cell enzyme abnormalities. In: Beutler E, Lichtman MA, Coller BS, et al, eds. Williams Hematology, 6th ed. 2001:527\u2013547."},{"key":"2019111702150470300_R2","unstructured":"Prchal JT and Gregg XT. Red cell enzymopathies. In: Hoffman R, Benz E, eds. Hematology: Basic Principles and Practice, 4th ed. 2005:653\u2013659."},{"key":"2019111702150470300_R3","doi-asserted-by":"crossref","unstructured":"Luzzatto L, Sodeinde O, Martini G. Genetic variation in the host and adaptive phenomena in Plasmodium falciparum infection. Ciba Found Symp. 1983;94:159\u2013173.","DOI":"10.1002\/9780470715444.ch10"},{"key":"2019111702150470300_R4","doi-asserted-by":"crossref","unstructured":"Roth EF Jr, Raventos-Suarez C, Rinaldi A, Nagel RL. Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc Natl Acad Sci U S A. 1983;80:298\u2013299.","DOI":"10.1073\/pnas.80.1.298"},{"key":"2019111702150470300_R5","doi-asserted-by":"crossref","unstructured":"Cappadoro M, Giribaldi G, O\u2019Brien E, et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood. 1998;92:2527\u20132534.","DOI":"10.1182\/blood.V92.7.2527"},{"key":"2019111702150470300_R6","doi-asserted-by":"crossref","unstructured":"Ruwende C, Khoo S, Snow R, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 1995;376:246\u2013249.","DOI":"10.1038\/376246a0"},{"key":"2019111702150470300_R7","doi-asserted-by":"crossref","unstructured":"Tishkoff SA, Varkonyi R, Cahinhinan N, et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science. 2001;293:455\u2013462.","DOI":"10.1126\/science.1061573"},{"key":"2019111702150470300_R8","unstructured":"Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods, 2nd ed. New York: Grune and Stratton; 1975."},{"key":"2019111702150470300_R9","doi-asserted-by":"crossref","unstructured":"Bianchi P, Zanella A. Hematologically important mutations: red cell pyruvate kinase (third update). Blood Cells Mol Dis. 2000;26:47\u201353.","DOI":"10.1006\/bcmd.2000.0276"},{"key":"2019111702150470300_R10","doi-asserted-by":"crossref","unstructured":"Valentini G, Chiarelli LR, Fortin R, et al. Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia. J Biol Chem. 2002;277:23807\u201323814.","DOI":"10.1074\/jbc.M202107200"},{"key":"2019111702150470300_R11","doi-asserted-by":"crossref","unstructured":"Aizawa S, Kohdera U, Hiramoto M, et al. Ineffective erythropoiesis in the spleen of a patient with pyruvate kinase deficiency. Am J Hematol. 2003;74:68\u201372.","DOI":"10.1002\/ajh.10380"},{"key":"2019111702150470300_R12","unstructured":"Aizawa S, Harada T, Kanbe E, et al. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity. Exp Hematol. In press."},{"key":"2019111702150470300_R13","doi-asserted-by":"crossref","unstructured":"Shimizu T, Uehara T, Nomura Y. Possible involvement of pyruvate kinase in acquisition of tolerance to hypoxic stress in glial cells. J Neurochem. 2004;91:167\u2013175.","DOI":"10.1111\/j.1471-4159.2004.02702.x"},{"key":"2019111702150470300_R14","doi-asserted-by":"crossref","unstructured":"Min-Oo G, Fortin A, Tam MF, et al. Pyruvate kinase deficiency in mice protects against malaria. Nat Genet. 2003;35:357\u2013362.","DOI":"10.1038\/ng1260"},{"key":"2019111702150470300_R15","doi-asserted-by":"crossref","unstructured":"Bianchi V, Spychala J. Mammalian 5\u2032-nucleotidases. J Biol Chem. 2003;278:46195\u201346198.","DOI":"10.1074\/jbc.R300032200"},{"key":"2019111702150470300_R16","doi-asserted-by":"crossref","unstructured":"Chiarelli LR, Bianchi P, Fermo E, et al. Functional analysis of pyrimidine 5\u2032-nucleotidase mutants causing nonspherocytic hemolytic anemia. Blood. 2005;105:3340\u20133345.","DOI":"10.1182\/blood-2004-10-3895"},{"key":"2019111702150470300_R17","doi-asserted-by":"crossref","unstructured":"Escuredo E, Marinaki AM, Duley JA, et al. The genetic basis of the interaction between pyrimidine 5\u2032 nucleotidase I deficiency and hemoglobin E. Nucleosides Nucleotides Nucleic Acids. 2004;23:1261\u20131263.","DOI":"10.1081\/NCN-200027532"},{"key":"2019111702150470300_R18","doi-asserted-by":"crossref","unstructured":"Kim J, Dang CV. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci. 2005;30:142\u2013150.","DOI":"10.1016\/j.tibs.2005.01.005"},{"key":"2019111702150470300_R19","doi-asserted-by":"crossref","unstructured":"Warburg O. On respiratory impairment in cancer cells. Science. 1956;124:269\u2013270.","DOI":"10.1126\/science.124.3215.269"},{"key":"2019111702150470300_R20","doi-asserted-by":"crossref","unstructured":"Warburg O. [New manometric 2-vessel method]. Hoppe Seylers Z Physiol Chem. 1967;348:1677\u20131682.","DOI":"10.1515\/bchm2.1967.348.1.1677"},{"key":"2019111702150470300_R21","doi-asserted-by":"crossref","unstructured":"Semenza GL. Intratumoral hypoxia, radiation resistance, and HIF-1. Cancer Cell. 2004;5:405\u2013406.","DOI":"10.1016\/S1535-6108(04)00118-7"},{"key":"2019111702150470300_R22","doi-asserted-by":"crossref","unstructured":"Mishra S, Raz A, Murphy LJ. Insulin-like growth factor binding protein-3 interacts with autocrine motility factor\/phosphoglucose isomerase (AMF\/PGI) and inhibits the AMF\/PGI function. Cancer Res. 2004;64:2516\u20132522.","DOI":"10.1158\/0008-5472.CAN-03-2877"},{"key":"2019111702150470300_R23","doi-asserted-by":"crossref","unstructured":"Majewski N, Nogueira V, Bhaskar P, et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell. 2004;16:819\u2013830.","DOI":"10.1016\/j.molcel.2004.11.014"},{"key":"2019111702150470300_R24","doi-asserted-by":"crossref","unstructured":"Xing C, LaPorte JR, Barbay JK, Myers AG. Identification of GAPDH as a protein target of the saframycin antiproliferative agents. Proc Natl Acad Sci U S A. 2004;101:5862\u20135866.","DOI":"10.1073\/pnas.0307476101"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2005\/1\/19\/645082\/019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2005\/1\/19\/645082\/019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T01:31:13Z","timestamp":1706751073000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2005\/1\/19\/19272\/Red-Cell-Enzymes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2005.1.19","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,1]]}}}